The FDAs decision was largely based on data from the SOUL trial, which included data from more than 9,000 patients who were randomized to oral semaglutide or a placebo.[1] All patients had type 2 diabetes in addition to known atherosclerotic cardiovascular disease, chronic kidney disease or both
10.1056/NEJMoa1614362 19 GhidewonM.WaldH
Generic versions of weight-loss drugs should arrive on Canadian pharmacy shelves this summer Patients in Canada have been paying between $300 and $400 a month for Ozempic and Wegovy, depending on the prescribed dose Last updated Mar 28, 2026 You can save this article by registering for free here
If you have a government insurance plan, like Medicare, you likely wont get coverage for Wegovy, but there are exceptions
You can also book an appointment through our website to see how semaglutide can help you manage your weight effectively
Patients undergoing chemotherapy have found relief through B12 supplementation as well